Ephedrine has a bad rap because of idiots with pre-existing conditions taking it, or people taking it in large doses, or combining it with things such as yohimbine (stupid, stupid)...
Here's a little bedtime reading that shows it is very safe when used properly (the last one is very interesting... study done on rats showing that ephedrine made them live longer *LOL*... BY THE GOVERNMENT!!).... 5 people died last year from ephedrine in the States... all of them mixed it with other shit... an estimated 200 million doses were taken in that year... 400 people died from ibuprofen (Advil) in the same year...
Chen KK, Schmidt CF. Ephedrine and related substances. Baltimore, The Williams & Wilkins company, 1930.
Weiner M. Weiner's Herbal: The Guide to Herb Medicine. Mill Valley, CA, Quantum Books, 1990.
Mahdihassan S, Mehdi FS. Soma of the Rigveda and an attempt to identify it. Amrerican Journal of Chinese Medicine 17(1-2): 1-8, 1989.
Astrup A, Buemann B, Christensen NJ, Toubro S, Thorbek G, Victor OJ, Quaade F. The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women. Metabolism: Clinical and Experimental. 41(7): 686-688, 1992.
Breum L, Pederson JK, Ahlstrom F, Frimodt-Moller. Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-center trial in general practice. International Journal of Obesity 18: 99-103, 1994.
Astrup A, Breum L, Toubro S, Hein P, Quaade F. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial. International Journal of Obesity 16(4): 269-77, 1992.
Dulloo AG, Miller DS. The Thermogenic Properties of Ephedrine /Methylxanthine Mixtures: Human Studies. International Journal of Obesity 10: 467-481, 1986.
Astrup A, Toubro S, Christensen NJ, Quaade F. Pharmacology of thermogenic drugs. American Journal of Clinical Nutrition 55(1 Supplement): 246S-248S, 1992.
Astrup A, Toubro S. Thermogenic, metabolic, and cardiovascular responses to ephedrine and caffeine in man. International Journal of Obesity 17 Supplement 1: S41-S43, 1993.
Astrup A, Lundsgaard C, Madsen J, Christensen NJ. Enhanced thermogenic respo nsiveness during chronic ephedrine treatment in man. American Journal of Clinical Nutrition 42: 83-94, 1985.
Dulloo AG, Miller DS. The Thermogenic Properties of Ephedrine /Methylxanthine Mixtures: Human Studies. International Journal of Obesity 10: 467-481, 1986.
Horton TJ, Geissler CA. Aspirin potentiates the effect of ephedrine on the thermogenic response to a meal in obese but not lean women. International Journal of Obesity 15(5): 359-366, 1991.
Buemann B, Marckmann P, Christensen NJ, Astrup A. The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet. International Journal of Obesity 18: 329-332, 1994.
Astrup A, Toubro S, Cannon S, Hein P, Madsen J. Thermogenic, metabolic, and cardiovascular effects of a sympathomimetic agent, ephedrine. Current Therapeutic Research, 48(6): 1087-1100, 1990.
Astrup A, Toubro S, Christensen NJ, Quaade F. Pharmacology of thermogenic drugs. American Journal of Clinical Nutrition 55(1 Supplement): 246S-248S, 1992.
Nishikawa T, Kimura T, Taguchi N, Dohi S. Oral clonidine preanesthetic medication augments the pressor responses to intravenous ephedrine in awake or anesthetized patients. Anesthesiology 74(4): 705-710, 1991.
Dullo AG, Seydoux J, Girardier L. Tealine and thermogenesis: Interactions between polyphenols, caffeine and sympathetic activity. International Journal of Obesity, May 1996, 20(Supplement 4):71 (abstract 08-178-WA1).
NTP technical report on the toxicology and carcinogenesis studies of ephedrine sulfate (CAS no. 134-72-5) in F344/N rats and B6C3F1 mice (feed studies) National Toxicology Program. U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health; Springfield, VA. Series title: NIH publication; no. 86-2563. Series title: Technical report series (National Toxicology Program (U.S.)); no. 307, 1986. (This NTP Technical Report 307 can be obtained by calling The National Toxicology Program @ (919) 541 -3419.)